What this study is
CHAOS is based on the investigator's new and exciting results from pre-clinical and large longitudinal multi-center observational clinical studies of critically ill patients and asymptomatic community-based adults with little or no advanced disease.
By integrating approaches from the physical, biological, computational, statistical and clinical sciences, this observational study will test the hypothesis that early diagnosis of subclinical signatures of critical illness encoded within physiological signals complements conventional clinical predictors by providing unique prognostic insight.
The primary goal is to reduce mortality, morbidity and complications by early identification of individuals with brewing subclinical critical illness and adverse events before overt clinical presentation (e.g., cardiac arrest, arrhythmias, hemorrhage, respiratory failure, circulatory collapse). This will provide the necessary lead time for healthcare providers to deliver early, more effective and/or preventive therapies. Through innovative approaches, CHAOS also meets the challenge of medical errors to reduce missed diagnosis, misdiagnosis, preventable harm and variability in provider adherence to best practice guidelines.
The goal is to validate predictive algorithms and identify subclinical signatures of illness, ranging from asymptomatic adults in the community to very sick patients in the hospital. The overall goal is to make healthcare more precise, effective, efficient, safe and timely while reducing costs, preventable harms and adverse events.
Study details
- Sponsor
- Johns Hopkins University
- Conditions
- Critical Illness · Death, Sudden
- Enrolling
- 200,000 people
- Starts
- 2019-09-01
- Est. completion
- 2027-09-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- All patients age 18-100 years admitted to a bed or OR with telemetry monitoring capability will be included.
You can't join if
- Children (individuals <18 years of age).
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (3)
3 openContact for every open site
- Deeptankar DeMazumder, MD, PhD · ContactDDeMazu@iu.edu
Indiana University
Indianapolis, Indiana, United States
Not yet recruitingJohns Hopkins University
Baltimore, Maryland, United States
- Steven R. Jones, MD · Contactsjones64@jhmi.edu
Not yet recruitingUniversity of Cincinnati
Cincinnati, Ohio, United States
- Benjamin L. Vaughan, PhD · Contactvaughabn@ucmail.uc.edu
Recruiting
Study team
Sponsor
Johns Hopkins University
Study ID CR02_2017-5045 (central IRB)
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.